Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP231448.RAf8SuMvh-OCIxset8Eu0U0HW4MGPDXff0372s3JB__J0130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP231448.RAf8SuMvh-OCIxset8Eu0U0HW4MGPDXff0372s3JB__J0130_provenance.
• NP505253.RAiOpl7bmEXVKoN5ilX7njO8p8hrqqeA_y88Twjex8XZk130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505253.RAiOpl7bmEXVKoN5ilX7njO8p8hrqqeA_y88Twjex8XZk130_provenance.
• NP694934.RAnuW5h53xt8VthZxg-1rqBm4NncIoTjjHk-6qqowT-iI130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694934.RAnuW5h53xt8VthZxg-1rqBm4NncIoTjjHk-6qqowT-iI130_provenance.
• NP345779.RAT7Q7UsaDednTJR4SOrw2twOoTOHyEYRnz7rddmqRKkk130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345779.RAT7Q7UsaDednTJR4SOrw2twOoTOHyEYRnz7rddmqRKkk130_provenance.
• NP628253.RAWhziUbOOFo-xGqHZgDW6COi4tOGneK0nGtGZ2neyIZQ130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP628253.RAWhziUbOOFo-xGqHZgDW6COi4tOGneK0nGtGZ2neyIZQ130_provenance.
• NP771285.RAS6WKZaCE05g8KCttsoSy1is38XvG1-a5fEB3lA0z5ec130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771285.RAS6WKZaCE05g8KCttsoSy1is38XvG1-a5fEB3lA0z5ec130_provenance.
• assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP406995.RA28VdjDFbLlkDhbF_qKccu1ZQpnecbPeekK6ShyXeJxo130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406995.RA28VdjDFbLlkDhbF_qKccu1ZQpnecbPeekK6ShyXeJxo130_provenance.
• NP394955.RATekRe-0D57F4NWaW7iYhjEat1lX5iDWyCJ7YfPl2lIY130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394955.RATekRe-0D57F4NWaW7iYhjEat1lX5iDWyCJ7YfPl2lIY130_provenance.
• NP395443.RAXo8A5ZryCgtyL7mrjPXUltQzopJBMqNc-VHKTeWyB9o130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395443.RAXo8A5ZryCgtyL7mrjPXUltQzopJBMqNc-VHKTeWyB9o130_provenance.
• assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP766317.RACNIDCAMYylr57PKzlf8o2UdFK0Ee3YluYWAj6GaOGks130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766317.RACNIDCAMYylr57PKzlf8o2UdFK0Ee3YluYWAj6GaOGks130_provenance.
• NP766318.RAEq_F4LSadETB52JdVl59IeKIqYkbHmsBDrIdZ68fAPc130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766318.RAEq_F4LSadETB52JdVl59IeKIqYkbHmsBDrIdZ68fAPc130_provenance.
• NP766314.RA3eVsgymq_hbQStmv3bmrNdgPpZzgVMtnnISJQT9fjjE130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766314.RA3eVsgymq_hbQStmv3bmrNdgPpZzgVMtnnISJQT9fjjE130_provenance.
• NP766323.RA80gty7m3DdYBIhuNOPsdrt6cDi8EQncKSTfmG3G2GEg130_assertion description "[Among colon cancer patients, CDK8 expression significantly increased colon cancer-specific mortality in both univariate analysis [HR 1.70; 95% confidence interval (CI), 1.03-2.83; p = 0.039] and multivariate analysis (adjusted HR 2.05; 95% CI, 1.18-3.56; p = 0.011) that was adjusted for potential confounders including beta-catenin, COX-2, FASN, LINE-1 hypomethylation, CIMP and MSI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766323.RA80gty7m3DdYBIhuNOPsdrt6cDi8EQncKSTfmG3G2GEg130_provenance.